Impact of renal function on mortality and incidence of major adverse cardiovascular events following acute coronary syndromes;Impacto da função renal na mortalidade e incidência de eventos cardiovasculares adversos major em doentes com síndromes coronárias agudas

Revista Portuguesa de Cardiologia

Volumn 29, Issue 9, 2010, Pages 1331-1352

  Lourenço, Carolina ^a   Teixeira, Rogério ^a   António, Natália ^a   Monteiro, Sílvia ^a   Baptista, Rui ^a   Jorge, Elisabete ^a   Gonçalves, Francisco ^a   Monteiro, Pedro ^a   Gonçalves, Lino ^a   Freitas, Mário ^a   Providência, Luís A ^a  

^a CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

Author keywords

Acute coronary syndrome; Prognosis; Renal failure; Treatment

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENOXAPARIN; FIBRINOGEN RECEPTOR ANTAGONIST; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TIROFIBAN;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; DYSLIPIDEMIA; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HEART CATHETERIZATION; HEART HEMODYNAMICS; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE; HIGH RISK PATIENT; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HYPERTENSION; KIDNEY DYSFUNCTION; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PATIENT ASSESSMENT; PROSPECTIVE STUDY; SMOKING; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STRESS; UNSTABLE ANGINA PECTORIS;

ACUTE CORONARY SYNDROME; AGED; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; INCIDENCE; KIDNEY; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 78751687453     PISSN: 08702551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Coca SG, Krumholz HM, Garg AX, et al. Underrepresentation of Renal Disease in Randomized Controlled Trials of Cardiovascular Disease. JAMA 2006;296:1377-1384. (Pubitemid 44427424)
2. Hemmelgarn BR, Southern DA, Humphries KH, Culleton BF, Knudtson ML, Ghali WA, for the Alberta Provincial Project for Outcomes Assessment in Coronary Heart Disease (APPROACH) Investigators. Refined characterization of the association between kidney function and mortality in patients undergoing cardiac catheterization. Eur Heart J 2006;27:1191-1197.
3. Anavekar NS, McMurray JJ, Velazquez EJ, et al. Relation between Renal Dysfunction and Cardiovascular Outcomes after Myocardial Infarction. N Engl J Med 2004;351:1285-1295.
4. Hemmelgarn BR, Southern D, Culleton BF, Mitchell LB, Knudtson ML, Ghali WA, for the Alberta Provincial Project for Outcomes Assessment in Coronary Heart Disease Investigators. Survival After Coronary Revascularization Among Patients With Kidney Disease. Circulation 2004;110:1890-1895.
5. Januzzi JL, Cannon CP, DiBattiste PM, Murphy S, Weintraub W, Braunwald E, for the TACTICS-TIMI 18 Investigators. Effects of Renal Insufficiency on Early Invasive Management in Patients With Acute Coronary Syndromes (The TACTICS-TIMI 18 Trial). Am J Cardiol 2002;90:1246-1249. (Pubitemid 35350859)
6. Bassand JP, Hamm CW, Ardissino D, et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J 2007; 28:1598-1660.
7. Gupta R, Birnbaum Y, Uretsky BF. The Renal Patient With Coronary Artery Disease - Current Concepts and Dilemmas. J Am Coll Cardiol 2004; 44:1343-1353.
8. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu C. Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization. N Engl J Med 2004;351:1296-1305.
9. Mielniczuk LM, Pfeffer MA, Lewis EF, et al. Estimated glomerular filtration rate, inflammation, and cardiovascular events after an acute coronary syndrome. Am Heart J 2008;155:725-731.
10. Deo R, Fyr CW, Fried LF, et al. Kidney dysfunction and fatal cardiovascular disease - an association independent of atherosclerotic events: Results from the Health, Aging, and Body Composition (Health ABC) study. Am Heart J 2008;155:62-68.
11. Hostetter TH. Chronic kidney disease predicts cardiovascular disease. N Engl J Med 2004;351:1344-1346.
12. Santopinto JJ, Fox KAA, Goldberg RJ, et al., on behalf of the GRACE Investigators. Creatinine clearance and adverse hospital outcomes in patients with acute coronary syndromes: findings from the global registry of acute coronary events (GRACE). Heart 2003; 89:1003-1008.
13. Shlipak MG, Fried LF, Cushman M, et al. Cardiovascular Mortality Risk in Chronic Kidney Disease: Comparison of Traditional and Novel Risk Factors. JAMA 2005; 293:1737-1745. (Pubitemid 40491299)
14. Kirtane AJ, Piazza G, Murphy SA, et al. Correlates of Bleeding Events Among Moderate-to High-Risk Patients Undergoing Percutaneous Coronary Intervention and Treated With Eptifibatide - Observations From the PROTECT-TIMI-30 Trial. J Am Coll Cardiol 2006; 47:2374-2379.
15. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification. Am J Kidney Dis 2002;39:S1-S266.
16. Bonello L, De Labriolle A, Roy P, et al. Impact of optimal medical therapy and revascularization on outcome of patients with chronic kidney disease and on dialysis who presented with acute coronary syndrome. Am J Cardiol. 2008 Sep 1; 102(5):535-40.